Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5495424
[patent_doc_number] => 20090263452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Drug-eluting intravascular prostheses and methods of use'
[patent_app_type] => utility
[patent_app_number] => 12/455521
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 29162
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263452.pdf
[firstpage_image] =>[orig_patent_app_number] => 12455521
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/455521 | Drug-eluting intravascular prostheses and methods of use | Jun 1, 2009 | Issued |
Array
(
[id] => 9827585
[patent_doc_number] => 08936811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-20
[patent_title] => 'Device coated with glycogen particles comprising nucleic acid complexes'
[patent_app_type] => utility
[patent_app_number] => 12/437287
[patent_app_country] => US
[patent_app_date] => 2009-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 14703
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12437287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/437287 | Device coated with glycogen particles comprising nucleic acid complexes | May 6, 2009 | Issued |
Array
(
[id] => 10870517
[patent_doc_number] => 08895715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'S100B mini-promoters'
[patent_app_type] => utility
[patent_app_number] => 12/387842
[patent_app_country] => US
[patent_app_date] => 2009-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10596
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12387842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387842 | S100B mini-promoters | May 6, 2009 | Issued |
Array
(
[id] => 4609381
[patent_doc_number] => 07994151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Compositions and methods for angiogenic therapy utilizing genes encoding ets-1'
[patent_app_type] => utility
[patent_app_number] => 12/435335
[patent_app_country] => US
[patent_app_date] => 2009-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 10245
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/994/07994151.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435335
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435335 | Compositions and methods for angiogenic therapy utilizing genes encoding ets-1 | May 3, 2009 | Issued |
Array
(
[id] => 5514332
[patent_doc_number] => 20090214638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'LIPOSOME ENCAPSULATED POLY-ICLC METHOD TO PROPHYLACTICALLY TREAT AN AVIAN INFLUENZA VIRAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/433961
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3638
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214638.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433961
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433961 | LIPOSOME ENCAPSULATED POLY-ICLC METHOD TO PROPHYLACTICALLY TREAT AN AVIAN INFLUENZA VIRAL INFECTION | Apr 30, 2009 | Abandoned |
Array
(
[id] => 5533578
[patent_doc_number] => 20090233366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'COMPOSITION FOR INTRODUCTION OF NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/432577
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10165
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233366.pdf
[firstpage_image] =>[orig_patent_app_number] => 12432577
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/432577 | COMPOSITION FOR INTRODUCTION OF NUCLEIC ACID | Apr 28, 2009 | Abandoned |
Array
(
[id] => 6007125
[patent_doc_number] => 20110059156
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-03-10
[patent_title] => 'Nanostructures Suitable for Sequestering Cholesterol and Other Molecules'
[patent_app_type] => utility
[patent_app_number] => 12/429560
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22301
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0059/20110059156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429560
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429560 | Nanostructures suitable for sequestering cholesterol and other molecules | Apr 23, 2009 | Issued |
Array
(
[id] => 6007125
[patent_doc_number] => 20110059156
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2011-03-10
[patent_title] => 'Nanostructures Suitable for Sequestering Cholesterol and Other Molecules'
[patent_app_type] => utility
[patent_app_number] => 12/429560
[patent_app_country] => US
[patent_app_date] => 2009-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22301
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A9/0059/20110059156.pdf
[firstpage_image] =>[orig_patent_app_number] => 12429560
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/429560 | Nanostructures suitable for sequestering cholesterol and other molecules | Apr 23, 2009 | Issued |
Array
(
[id] => 5551895
[patent_doc_number] => 20090285881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'CATIONIC LIPIDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/425198
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 39918
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285881.pdf
[firstpage_image] =>[orig_patent_app_number] => 12425198
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/425198 | CATIONIC LIPIDS AND USES THEREOF | Apr 15, 2009 | Abandoned |
Array
(
[id] => 9127174
[patent_doc_number] => 08575123
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => 'Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components'
[patent_app_type] => utility
[patent_app_number] => 12/936961
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 11
[patent_no_of_words] => 74875
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936961
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936961 | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components | Apr 9, 2009 | Issued |
Array
(
[id] => 7568097
[patent_doc_number] => 20110288160
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'Treatment of Metabolic-Related Disorders Using Hypothalamic Gene Transfer of BDNF and Compositions Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/934735
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 19638
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 57
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20110288160.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934735
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934735 | Treatment of metabolic-related disorders using hypothalamic gene transfer of BDNF and compositions therefor | Mar 26, 2009 | Issued |
Array
(
[id] => 8642425
[patent_doc_number] => 08367407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Cells with altered fucosylation and producing antibodies therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/409587
[patent_app_country] => US
[patent_app_date] => 2009-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 73
[patent_no_of_words] => 77442
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12409587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409587 | Cells with altered fucosylation and producing antibodies therefrom | Mar 23, 2009 | Issued |
Array
(
[id] => 7560838
[patent_doc_number] => 20110274670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'MESENCHYMAL STEM CELLS WHICH EXPRESS HUMAN HEPATIC GROWTH FACTOR,MANUFACTURING METHOD THEREOF, AND USE THEREOF AS THERAPEUTIC AGENT FOR LIVER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/997875
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7903
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20110274670.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997875 | MESENCHYMAL STEM CELLS WHICH EXPRESS HUMAN HEPATIC GROWTH FACTOR,MANUFACTURING METHOD THEREOF, AND USE THEREOF AS THERAPEUTIC AGENT FOR LIVER DISEASES | Mar 19, 2009 | Abandoned |
Array
(
[id] => 6118579
[patent_doc_number] => 20110076252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'COMPOUND AND METHOD FOR TREATMENT OF GASTROESOPHAGEAL REFLUX'
[patent_app_type] => utility
[patent_app_number] => 12/933440
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4601
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076252.pdf
[firstpage_image] =>[orig_patent_app_number] => 12933440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/933440 | Compound and method for treatment of gastroesophageal reflux | Mar 19, 2009 | Issued |
Array
(
[id] => 5533571
[patent_doc_number] => 20090233359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'POLYMERS AND COMPLEXES FOR DELIVERY OF NUCLEIC ACIDS TO INTRACELLULAR TARGETS'
[patent_app_type] => utility
[patent_app_number] => 12/405313
[patent_app_country] => US
[patent_app_date] => 2009-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15187
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20090233359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12405313
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/405313 | Polymers and complexes for delivery of nucleic acids to intracellular targets | Mar 16, 2009 | Issued |
Array
(
[id] => 4455247
[patent_doc_number] => 07892534
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Differentiating human trophoblast stem cells in mammalian straitum'
[patent_app_type] => utility
[patent_app_number] => 12/405112
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 64
[patent_no_of_words] => 12465
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892534.pdf
[firstpage_image] =>[orig_patent_app_number] => 12405112
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/405112 | Differentiating human trophoblast stem cells in mammalian straitum | Mar 15, 2009 | Issued |
Array
(
[id] => 6151005
[patent_doc_number] => 20110022027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'DRUG-ELUTING CATHETER AND METHOD OF MANUFACTURING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/921443
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 15621
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20110022027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921443
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921443 | Drug-eluting catheter and method of manufacturing the same | Mar 11, 2009 | Issued |
Array
(
[id] => 5533096
[patent_doc_number] => 20090232884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'Composition and method for treatment of the side-effects associated with administration of cancer chemotherapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 12/381474
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2895
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20090232884.pdf
[firstpage_image] =>[orig_patent_app_number] => 12381474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/381474 | Composition and method for treatment of the side-effects associated with administration of cancer chemotherapeutic agents | Mar 11, 2009 | Abandoned |
Array
(
[id] => 6024591
[patent_doc_number] => 20110052917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'COPOLYMER INCLUDING UNCHARGED HYDROPHILIC BLOCK AND CATIONIC POLYAMINO ACID BLOCK HAVING HYDROPHOBIC GROUP IN PART OF SIDE CHAINS, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/922116
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8099
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052917.pdf
[firstpage_image] =>[orig_patent_app_number] => 12922116
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922116 | Copolymer including uncharged hydrophilic block and cationic polyamino acid block having hydrophobic group in part of side chains, and use thereof | Mar 5, 2009 | Issued |
Array
(
[id] => 10648337
[patent_doc_number] => 09364566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Aqueous formulation for selective targeting and delivering gene to cancer cells'
[patent_app_type] => utility
[patent_app_number] => 12/394578
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5031
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12394578
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394578 | Aqueous formulation for selective targeting and delivering gene to cancer cells | Feb 26, 2009 | Issued |